Celest Investments Pty Limited

Status: Registered
Current name since: 2009-03-25
Name in the ASICs register: Celest Investments Pty Limited
Australian Company Number: 131641711
Australian Business Number: 89131641711
Registration date: 2008-06-16
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Celest Investments Pty Limited is a limited by shares, Australian proprietary company. This corporation was registered on 2008-06-16 and was issued with the 131641711 ACN. Its Australian Business Number is 89131641711. Since 2014-09-23, the company is headquartered in NSW, post code 2102. The previous headquarters were located in NSW 2102 (from 2014-01-20 to 2014-09-23), NSW 2102 (from 2008-06-16 to 2014-01-20). The above data comes from the ABN database which was updated on 2014-10-02.

Details for ABN 89131641711

Type: Australian Private Company

ABN Status

Status From To
Cancelled 2013-07-01 current
Active 2008-06-16 2013-07-01

Main Name

Name From To
Celest Investments Pty Limited 2009-03-25 current
Adcock Superannuation Fund Pty. Limited 2008-06-16 2009-03-25

Main Location

Location From To
NSW 2102 2014-09-23 current
NSW 2102 2014-01-20 2014-09-23
NSW 2102 2008-06-16 2014-01-20

Advertisements

Find company

NSW 2102 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.